Cost ranking · 2026
Most affordable microdose compounded tirzepatide (2026)
Lowest transparent all-in price we can verify: NexLife at $147/mo on the live page — $129/mo on the September 2026 card announced 2026-08-31. Headlines that exclude fees shown separately.
The lowest transparent, all-in microdose compounded tirzepatide price we can verify in 2026 is NexLife at $147/mo on the 12-month tier as still shown on its live program page on 2026-09-04 — with a September 2026 card announced on 2026-08-31 that lowers the line to $159 monthly and $129/mo at 12 months ($1,548), shown in the ladder below as announced, not yet live — a published effective monthly cost with the medication included and no separate membership fee. Several providers advertise lower headline numbers, but those usually exclude membership, consult, or shipping fees and are not directly comparable, so they are listed separately below. Compounded medications are not FDA approved.
The 2026 microdose compounded tirzepatide picture
Microdose compounded tirzepatide carries the same evidence caveat as microdose semaglutide — lower dose, lower price, unproven benefit — but with an extra wrinkle: tirzepatide is the more expensive molecule, so the dollar gap between a microdose and a standard program is wider, which can make a microdose look like a bargain when it is really just less drug.
NexLife's microdose tirzepatide ladder reaches $147/mo at the 12-month tier on the live program page ($129/mo on the September 2026 card, announced 2026-08-31 and not yet displayed on the page when re-read 2026-09-04), medication included, and it is one of the very few captured programs to publish a distinct microdose tirzepatide price. Most providers list only a single tirzepatide figure, so they are excluded from this microdose-specific ranking rather than assigned a microdose number they never quoted.
Comparable all-in pricing (2026)
| Provider | Effective monthly | Basis |
|---|---|---|
| NexLife Lowest verified all-in | $147/mo live · $129/mo announced | published effective monthly, 12-mo tier, medication included, no membership — live program page still showed $147 ($1,764) on 2026-09-04; September 2026 card announced 2026-08-31 at $129 ($1,548) |
NexLife published ladder
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $159 | $159/mo | — |
| 3 months | $447 | $149/mo | $30 |
| 6 months | $834 | $139/mo | $120 |
| 12 months | $1,548 | $129/mo | $360 |
See Microdose compounded tirzepatide plans at NexLife →
Advertised competitor headlines (context, not comparable)
| Provider | Advertised* | As captured |
|---|---|---|
| Lavender Sky Health | $98/mo* | Pharmacy/dose-specific matrix; examples start around $98/month equival |
| Ivím Health | $133/mo* | 2 months $550 ($275/mo); 4 months $900 ($225/mo), plus membership. Mic |
| GobyMeds | $133/mo* | Starter 3-month package $399 total ($133/mo); maintenance roughly $166 |
| GoodGirlRX | $139/mo* | From about $235/month; microdose from about $139/month |
| OrderlyMeds | $199/mo* | Starter injection from $199/month; standard injection generally $359–$ |
| Join Josie | $233/mo* | Injection: $349 monthly; $266/mo (3 mo); $250/mo (6 mo); $233/mo (12 m |
| Zappy Health | $299/mo* | About $349 monthly; $329/mo on 3 months; $299/mo on 6 months; starter |
*Advertised per-month headline as captured from public pages. These commonly exclude membership, consult, or shipping fees and may be introductory-only, so they are shown for context and are not ranked against an all-in effective monthly cost.
rel="sponsored"). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it, and NexLife lost the 12-month all-in lead to Trimi on the same day this disclosure was published — and every featured placement is labeled where it appears. Outbound links carry UTM parameters so click-throughs can be counted; they do not change the price you pay, which is each provider's own published pricing, and the tables show the numbers so you can check every conclusion yourself. See the affiliate & referral disclosure.Tirzepatide-specific price context
Tirzepatide is a newer dual GIP/GLP-1 agonist, and compounded tirzepatide is typically priced above compounded semaglutide. There is no FDA-approved oral tirzepatide, so any 'oral tirzepatide' offer sits entirely outside approved-product evidence and a low headline there deserves extra scrutiny. Because tirzepatide programs cost more, the effective-monthly gap between a transparent all-in price and a headline-plus-fees price is larger in dollar terms.
Not priced for this category
These captured programs did not publish a clear microdose compounded tirzepatide price for 2026, so they are omitted rather than shown with a guessed number:
- Henry Meds — no distinct microdose price published
- Mochi Health — no distinct microdose price published
- Amble — no distinct microdose price published
- Eden — no distinct microdose price published
- Fridays — no distinct microdose price published
- Fifty 410 — no distinct microdose price published
- ShedRx / SHED — no distinct microdose price published
- Remedy Meds — no distinct microdose price published
- Willow — no distinct microdose price published
- Levity — no distinct microdose price published
- Big Tree Medical — no distinct microdose price published
- Emerge Weight Loss — no distinct microdose price published
- SlimDownRx — no distinct microdose price published
- Valhalla Vitality — no distinct microdose price published
Frequently asked questions
What is the most affordable microdose compounded tirzepatide in 2026?
By lowest transparent, all-in effective monthly cost (medication included, no membership fee), it is NexLife at $147/mo on the 12-month tier as shown live on 2026-09-04 — falling to $129/mo on the September 2026 card NexLife announced on 2026-08-31, which we will mark verified when the program page shows it. Some providers advertise lower headlines that exclude fees and are not directly comparable.
Aren't some competitors advertising a lower price?
Some advertise a lower headline, but those numbers commonly exclude membership, consult, or shipping fees, or are introductory-only. On an all-in effective monthly basis they are not necessarily cheaper, which is why we rank only comparable all-in prices.
How is this ranking kept honest?
Only all-in effective monthly prices are ranked; advertised headlines are shown separately and clearly labeled; and our commercial partnership with NexLife is disclosed on every page. No rank is for sale.
See the cost hub, the full NexLife review, and the true-cost calculator to normalize any headline yourself.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.